Fig. 4From: Downregulation of B3GNT6 is a predictor of poor outcomes in patients with colorectal cancerIncreased B3GNT6 expression predicts better overall survival in patients with colorectal cancer. A, B Both the discovery and validation cohorts in GSE39582 comprised patients with high B3GNT6 mRNA levels showed better overall survival. C This was further validated using clinical data from TCGA online databaseBack to article page